Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

References for PMC Articles for PubMed (Select 19908231)

1.

Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.

Bernhaus A, Ozsvar-Kozma M, Saiko P, Jaschke M, Lackner A, Grusch M, Horvath Z, Madlener S, Krupitza G, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T.

Invest New Drugs. 2009 Oct;27(5):393-401. doi: 10.1007/s10637-008-9183-7. Epub 2008 Oct 8.

PMID:
18841326
2.

SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation.

Sethi G, Ahn KS, Sung B, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB.

Biochem Pharmacol. 2008 Dec 1;76(11):1404-16. doi: 10.1016/j.bcp.2008.05.023. Epub 2008 Jul 5.

PMID:
18606397
3.

Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB.

J Natl Cancer Inst. 2008 Jun 4;100(11):773-83. doi: 10.1093/jnci/djn148. Epub 2008 May 27. Review.

4.

New directions in the management of advanced pancreatic cancer: a review.

Rocha-Lima CM.

Anticancer Drugs. 2008 Jun;19(5):435-46. doi: 10.1097/CAD.0b013e3282fc9d11. Review.

PMID:
18418211
5.

Resveratrol: a multitargeted agent for age-associated chronic diseases.

Harikumar KB, Aggarwal BB.

Cell Cycle. 2008 Apr 15;7(8):1020-35. Epub 2008 Feb 15. Review.

6.

Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.

Verma A, Guha S, Diagaradjane P, Kunnumakkara AB, Sanguino AM, Lopez-Berestein G, Sood AK, Aggarwal BB, Krishnan S, Gelovani JG, Mehta K.

Clin Cancer Res. 2008 Apr 15;14(8):2476-83. doi: 10.1158/1078-0432.CCR-07-4529.

7.

Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.

Pan MH, Gao JH, Lai CS, Wang YJ, Chen WM, Lo CY, Wang M, Dushenkov S, Ho CT.

Mol Carcinog. 2008 Mar;47(3):184-96.

PMID:
18085528
8.

Pancreatic cancer.

Maitra A, Hruban RH.

Annu Rev Pathol. 2008;3:157-88. Review.

9.

Resveratrol suppresses prostate cancer progression in transgenic mice.

Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA.

Carcinogenesis. 2007 Sep;28(9):1946-53. Epub 2007 Aug 3.

10.

Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo.

Li T, Fan GX, Wang W, Li T, Yuan YK.

Int Immunopharmacol. 2007 Sep;7(9):1221-31. Epub 2007 Jun 12.

PMID:
17630201
11.

High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.

Weichert W, Boehm M, Gekeler V, Bahra M, Langrehr J, Neuhaus P, Denkert C, Imre G, Weller C, Hofmann HP, Niesporek S, Jacob J, Dietel M, Scheidereit C, Kristiansen G.

Br J Cancer. 2007 Aug 20;97(4):523-30. Epub 2007 Jul 10.

12.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52.

14.

Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.

Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE.

J Surg Res. 2007 Apr;138(2):163-9. Epub 2007 Jan 25.

PMID:
17257620
15.

Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation.

Shibata MA, Akao Y, Shibata E, Nozawa Y, Ito T, Mishima S, Morimoto J, Otsuki Y.

Cancer Chemother Pharmacol. 2007 Oct;60(5):681-91. Epub 2007 Jan 26.

PMID:
17256131
16.

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.

Arumugam T, Ramachandran V, Logsdon CD.

J Natl Cancer Inst. 2006 Dec 20;98(24):1806-18.

17.

Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.

Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB.

Blood. 2007 Mar 15;109(6):2293-302. Epub 2006 Dec 12. Erratum in: Blood. 2013 Aug 15;122(7):1325-6.

18.

Therapeutic potential of resveratrol: the in vivo evidence.

Baur JA, Sinclair DA.

Nat Rev Drug Discov. 2006 Jun;5(6):493-506. Epub 2006 May 26. Review.

PMID:
16732220
19.

Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.

Rezk YA, Balulad SS, Keller RS, Bennett JA.

Am J Obstet Gynecol. 2006 May;194(5):e23-6. Epub 2006 Apr 21.

PMID:
16647892
20.

Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound.

Chen JC, Chen Y, Lin JH, Wu JM, Tseng SH.

Anticancer Res. 2006 Mar-Apr;26(2A):1237-45.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk